Patent Application
20220022513
Sebacic acid is a white flake or powdered crystal slightly soluble in water. Sebacic acid and its derivatives such as azelaic acid have a variety of industrial uses as plasticizers, lubricants, hydraulic fluids, cosmetics, and candles. It is also used in the synthesis of polyamide and alkyd resins and as an intermediate for aromatics, antiseptics and painting materials.
This invention provides a consumable composed of a carbohydrate sweetener or flavoring and sebacic acid, wherein the consumable may be a food product, pharmaceutical composition, a dietary supplement, a nutraceutical, a dental hygienic composition, a tabletop sweetener, a beverage, or a cosmetic product. A method for enhancing the sweetness or mouthfeel of a consumable by adding sebacic acid to the consumable is also provided. In certain embodiments, the compositions and method further include the use of traumatic acid and/or an isomer thereof such as 3-dodecenedioic acid.
It has now been found that sebacic acid exhibits a sweet enhancement effect as well as mouthfeel modifying functionalities. Accordingly, the present invention provides compositions and methods, which use sebacic acid as an additive to enhance the sweetness and mouthfeel of a consumable.
As is known in the art, sebacic acid or decanedioic acid (CAS No. 111-20-6) is a linear, saturated dicarboxylic acid. Sebacic acid of use in this invention may be obtained from a natural source or prepared by synthetic methods. Natural sources of sebacic acid include royal jelly (Moutsatsou, et al. (2010) PLoS ONE 5: e15594), Boehmeria nivea, Caesalpinia pulcherrima and Agave americana (Matic (1956) Biochem. J. 63(1):168-176). Sebacic acid may be isolated from one or more of these natural sources by ether extraction and sequential alkalization, acidification and ether extraction (Brown & Freure (1959) Can. J. Chem. 37:2042-2046); or extraction with an aqueous solution at elevated temperatures (e.g., 50-100° C.) followed by separation of the two immiscible phases and precipitation of the dicarboxylic acids by cooling to aqueous phase (U.S. Pat. No. 2,798,093). Chromatographic fractionation typically includes column chromatography and may based on molecular sizing, charge, solubility and/or polarity. Depending on the type of chromatographic method, column chromatography can be carried out with matrix materials composed of, for example, dextran, agarose, polyacrylamide or silica and can include solvents such as dimethyl sulfoxide, pyridine, water, dimethylformamide, methanol, saline, ethylene dichloride, chloroform, propanol, ethanol, isobutanol, formamide, methylene dichloride, butanol, acetonitrile, isopropanol, tetrahydrofuran, dioxane, chloroform/dichloromethane, etc. Typically, the product of the chromatographic step is collected in multiple fractions, which may then be tested for the presence of the desired compound using any suitable analytical technique (e.g., thin layer chromatography, mass spectrometry). Fractions enriched in the desired compound may then be selected for further purification.
Alternatively, sebacic acid may be synthesized. For example, sebacic acid can be synthesized by castor oil electrooxidation (U.S. Pat. No. 4,237,317), which produces high purity sebacic acid from readily available adipic acid. The process includes the steps of partially esterifying adipic acid to form monomethyl adipate, subjecting the potassium salt of monomethyl adipate in a mixture of methanol and water to electrolysis to give dimethyl sebacate, and hydrolyzing the dimethyl sebacate to sebacic acid. In yet other embodiments, sebacic acid is obtained from a commercial source such as Cayman Chemical (Ann Arbor, Mich.) or Sigma-Aldrich (St. Louis, Mo.). In particular embodiments, the sebacic acid is purified to at least 95%, 96%, 97%, 98%, 99% or 100% homogeneity.
While salts of sebacic acid may be used in this invention, preferably the sebacic acid is not derivatized or conjugated to another molecule, i.e., the sebacic acid is unconjugated sebacic acid.
As described herein, sebacic acid enhances the taste and flavor of consumables. The taste and flavor profile of a consumable including sebacic acid may be enhanced or more intense (e.g., by 5%, 10%, 20%, 30% or more intense) than a comparative taste and flavor profile of a comparative consumable which does not include sebacic acid as an additive. Further, the mouthfeel of a consumable including sebacic acid may be improved in relation to the mouthfeel of a comparative consumable that does not include sebacic acid.
In particular embodiments, sebacic acid enhances the sweetness and mouthfeel of a consumable containing a carbohydrate sweetener or flavoring. As used herein, the term “sweetness” or “sweetness intensity” refers to the relative strength of sweet sensation as observed or experienced by an individual, e.g., a human, or a degree or amount of sweetness detected by a taster, for example on the scale from 0 (none) to 8 (very strong) used in sensory evaluations according to the procedure described in American Society for Testing Materials, Special Technical Publication-434: “Manual on Sensory Testing Methods,” ASTM International, West Conshohocken, Pa. (1996). The mouthfeel of a substance relates to the physical sensations in the mouth produced by a particular food. By way of illustration, a “sugary mouthfeel” is the physical sensation observed or experienced by an individual, e.g., a human, upon consumption of a sugar. In accordance with the present invention, sebacic acid enhances at least sweet/sugary mouthfeel and optionally fatty mouthfeel.
As used herein, a consumable includes all food products, pharmaceutical compositions, dietary supplements, nutraceuticals, dental hygienic compositions, tabletop sweeteners, beverages, or cosmetic products. In some embodiments, the consumable includes one or more carbohydrate sweeteners or flavorings. The carbohydrate sweetener or flavoring can be present in the consumable inherently (e.g., in food products containing fruits) or the carbohydrate sweetener or flavoring is added into the consumable (i.e., an exogenous sweetener or flavoring). Suitable carbohydrate sweeteners of the present invention include, but are not limited to, sucrose, fructose, glucose, high fructose corn syrup (containing fructose and glucose), xylose, arabinose, rhamnose, and sugar alcohols, such as erythritol, xylitol, mannitol, sorbitol, or inositol. In one embodiment, the carbohydrate sweetener is sucrose, fructose, glucose, high fructose corn syrup, xylose, arabinose or rhamnose, preferably sucrose, fructose, or glucose. In one aspect of this embodiment, the carbohydrate sweetener is sucrose. In another aspect of this embodiment, the carbohydrate sweetener is glucose. In another aspect of this embodiment, the carbohydrate sweetener is fructose. In another embodiment, the carbohydrate sweetener is a sugar alcohol, e.g., erythritol, xylitol, mannitol, sorbitol, or inositol.
Flavorings of use in this invention include, but are not limited to, Natural Sweet Flavor #2 (WO 2012/129451), stevioside, rebaudioside A, rebaudioside B, rebaudioside C, rebaudioside D, rebaudioside E, rebaudioside F, dulcoside A, dulcoside B, stevia, alpha-glucosyl stevia, fructosyl stevia, galactosyl stevia, beta-glucosyl stevia, siamenoside, mogroside IV, mogroside V, Luo Han Guo sweetener, monatin and its salts, glycyrrhizic acid and its salts (e.g., as found in MAGNASWEET), curculin, thaumatin, monellin, mabinlin, brazzein, hernandulcin, phyllodulcin, glycyphyllin, phloridzin, trilobtain, baiyunoside, osladin, polypodoside A, pterocaryoside A, pterocaryoside B, mukurozioside, phlomisoside I, periandrin I, abrusoside A, cyclocarioside I, or a combination thereof. In certain embodiments, the flavoring is Natural Sweet Flavor #2 (also known as NSF-02), which contains glucosylated steviol glycosides and dextrin.
When added to a consumable as an additive, sebacic acid is used in an amount effective to enhance the sweetness or mouthfeel of a carbohydrate sweetener or flavoring without exhibiting any off-taste. Any amount of sebacic acid that provides the desired degree of sweetness or mouthfeel enhancement can be used. Preferably, the amount of sebacic acid present in the consumable is an amount as low as 0.05 ppm, in an amount as low as 0.2 ppm, in an amount as low as 1 ppm, or in an amount as low as 10 ppm. The sebacic acid can be included in the consumable in an amount that is as high as 1000 ppm, in an amount as high as 500 ppm, or in an amount as high as 100 ppm. The sebacic acid may further be present within any range delimited by any pair of the foregoing values, such as between 0.2 ppm and 1000 ppm, or between 1 ppm and 100 ppm, for example. The term “ppm” as used herein means part per million by weight or volume, for example, the weight of the component (in milligrams) per liter of solution, i.e., μg/ml.
In some embodiments, the invention embraces a combination of sebacic acid and traumatic acid (CAS No. 6402-36-4) and/or its isomer, 3-dodecenedioic acid (CAS No. 189034-80-8. In particular embodiments, the weight ratio of traumatic acid (or its isomer) to sebacic acid is at least 1:1, 2:1, 3:1, 4:1, 5:1, 6:1, 7:1, 8:1, or 9:1.
The phrase “food product” as used herein includes, but is not limited to, fruits, vegetables, juices, meat products (e.g., ham, bacon and sausage), egg products, fruit concentrates, gelatins and gelatin-like products (e.g., jams, jellies, preserves, and the like) milk products (e.g., ice cream, sour cream and sherbet), icings, syrups including molasses, corn products, wheat products, rye products, soybean products, oat products, rice products and barley products, nut meats and nut products, cakes, cookies, confectionaries (e.g., candies, gums, fruit flavored drops, and chocolates), chewing gum, mints, creams, ice cream, pies and breads, and beverages such as coffee, tea, carbonated soft drinks (e.g., soft drinks sold under the tradenames COKE® and PEPSI®), non-carbonated soft drinks, juices and other fruit drinks, sports drinks such as those sold under the tradename GATORADE®, alcoholic beverages, such as beers, wines and liquors, and flavored drinks sold under the tradename KOOL-AID®. Food products also include condiments such as herbs, spices and seasonings, and flavor enhancers, such as monosodium glutamate. A food product also includes prepared packaged products, such as dietetic sweeteners, liquid sweeteners, granulated flavor mixes which upon reconstitution with water provide non-carbonated drinks, instant pudding mixes, instant coffee and tea, coffee whiteners, malted milk mixes, pet foods, livestock feed, tobacco, and materials for baking applications, such as powdered baking mixes for the preparation of breads, cookies, cakes, pancakes, donuts and the like. Food products also include diet or low-calorie food and beverages containing little or no sucrose. Especially preferred food products are carbonated beverages. Preferably, the consumable in which the sweetness or mouthfeel is enhanced contains a decreased level of the carbohydrate sweetener. For example, an improved carbonated soft drink can be produced with the same sweetness as the known carbonated soft drink but with a lower sugar content by adding sebacic acid.
The consumable can also be a pharmaceutical composition. Preferred compositions are pharmaceutical compositions containing sebacic acid and one or more pharmaceutically acceptable excipients. These pharmaceutical compositions can be used to formulate pharmaceutical drugs containing one or more active agents that exert a biological effect other than sweetness enhancement. The pharmaceutical composition preferably further includes one or more active agents that exert a biological effect. Such active agents include pharmaceutical and biological agents that have an activity other than taste enhancement. Such active agents are well known in the art. See, e.g., The Physician's Desk Reference. Such compositions can be prepared according to procedures known in the art, for example, as described in Remington's Pharmaceutical Sciences, Mack Publishing Co., Easton, Pa. In one embodiment, such an active agent includes bronchodilators, anorexiants, antihistamines, nutritional supplements, laxatives, analgesics, anesthetics, antacids, H2-receptor antagonists, anticholinergics, antidiarrheals, demulcents, antitussives, antinauseants, antimicrobials, antibacterials, antifungals, antivirals, expectorants, anti-inflammatory agents, antipyretics, and mixtures thereof. In one embodiment, the active agent is a antipyretic or analgesic, e.g., ibuprofen, acetaminophen, or aspirin; laxative, e.g., phenolphthalein dioctyl sodium sulfosuccinate; appetite depressant, e.g., amphetamine, phenylpropanolamine, phenylpropanolamine hydrochloride, or caffeine; antacidic, e.g., calcium carbonate; antiasthmatic, e.g., theophylline; antidiuretic, e.g., diphenoxylate hydrochloride; agent active against flatulence, e.g., simethecon; migraine agent, e.g., ergotaminetartrate; psychopharmacological agent, e.g., haloperidol; spasmolytic or sedative, e.g., phenobarbitol; antihyperkinetic, e.g., methyldopa or methylphenidate; tranquilizer, e.g., a benzodiazepine, hydroxinmeprobramate or phenothiazine; antihistaminic, e.g., astemizol, chloropheniramine maleate, pyridamine maleate, doxlamine succinate, bromopheniramine maleate, phenyltoloxamine citrate, chlorocyclizine hydrochloride, pheniramine maleate, or phenindamine tartrate; decongestant, e.g., phenylpropanolamine hydrochloride, phenylephrine hydrochloride, pseudoephedrine hydrochloride, pseudoephedrine sulfate, phenylpropanolamine bitartrate, or ephedrine; beta-receptor blocker, e.g., propanolol; agent for alcohol withdrawal, e.g., disulfuram; antitussive, e.g., benzocaine, dextromethorphan, dextromethorphan hydrobromide, noscapine, carbetapentane citrate, or chlophedianol hydrochloride; fluorine supplement, e.g., sodium fluoride; local antibiotic, e.g., tetracycline or cleocine; corticosteroid supplement, e.g., prednisone or prednisolone; agent against goiter formation, e.g., colchicine or allopurinol; antiepileptic, e.g., phenyloine sodium; agent against dehydration, e.g., electrolyte supplement; antiseptic, e.g., cetylpyridinium chloride; NSAID, e.g., acetaminophen, ibuprofen, naproxen, or salt thereof; gastrointestinal active agent, e.g., loperamide and famotidine; an alkaloid, e.g., codeine phosphate, codeine sulfate, or morphine; supplement for a trace element, e.g., sodium chloride, zinc chloride, calcium carbonate, magnesium oxide, or other alkali metal salt or alkali earth metal salt; vitamin; ion-exchange resin, e.g., cholestyramine; cholesterol-depressant or lipid-lowering substance; antiarrhythmic, e.g., N-acetylprocainamide; or expectorant, e.g., guaifenesin.
In some embodiments, the consumable is a dietary supplement or nutraceutical. Examples of such compositions having an undesirable taste include, but are not limited to, enteral nutrition products for treatment of nutritional deficit, trauma, surgery, Crohn's disease, renal disease, hypertension, obesity and the like, to promote athletic performance, muscle enhancement or general well-being or inborn errors of metabolism such as phenylketonuria. In particular, such compositions can contain one or more amino acids which have a bitter or metallic taste or aftertaste. Such amino acids include, but are not limited to, essential amino acids such as L isomers of leucine, isoleucine, histidine, lysine, methionine, phenylalanine, threonine, tryptophan, tyrosine, and valine.
In a further embodiment, the consumable of the present invention is a dental hygienic composition, containing a carbohydrate sweetener or flavoring and sebacic acid. Dental hygienic compositions are known in the art and include, but are not necessarily limited to, toothpaste, mouthwash, plaque rinse, dental floss, dental pain relievers (such as ANBESOL™), and the like. In one embodiment, the dental hygienic composition includes one carbohydrate sweetener. In another embodiment, the dental hygienic composition includes more than one carbohydrate sweetener. In certain embodiments, the dental hygienic composition includes sucrose and corn syrup, or sucrose and aspartame.
In yet another embodiment, the consumable of the present invention is a cosmetic product containing a carbohydrate sweetener or flavoring and sebacic acid. For example, but not by way of limitation, the cosmetic product can be a face cream, lipstick, lip gloss, and the like. Other suitable compositions of the invention include lip balm, such as lip balm sold under the tradename CHAPSTICK® or BURT'S BEESWAX®.
When used in the methods and compositions of this invention, sebacic acid is added to a consumable (i.e., the sebacic acid is not an endogenous component of the consumable) in an amount effective to enhance the sweetness or mouthfeel of the consumable including a carbohydrate sweetener or flavoring. In this respect, the amount of carbohydrate sweetener or flavoring added to the consumable may be reduced while retaining the desired sweetness level. Thus, the present invention also provides methods and compositions for enhancing the sweetness and mouthfeel of a carbohydrate sweetener and/or flavoring and decreasing the amount of a carbohydrate sweetener and/or flavoring in a consumable by combining the carbohydrate sweetener and/or flavoring with sebacic acid. In some embodiments, the carbohydrate sweetener or flavoring and sebacic acid are used at a 10000:1, 1000:1, or 100:1 ratio. In one embodiment, the invention provides a consumable containing an effective amount of a combination of sebacic acid and a carbohydrate sweetener or flavoring in a reduced amount in order to achieve the same level of sweetness when the carbohydrate sweetener or flavoring is used alone in the traditional amount. In this respect, the amount of carbohydrate sweetener or flavoring used in a consumable can be reduced by at least about 5%, 10%, 20%, or 30%. Unless otherwise specified, percentages (%) are by weight.
The invention is described in greater detail by the following non-limiting examples.
Sugar water (4% sucrose in drinking water) was prepared and used as a base solution. Different amounts of sebacic acid were added to the base solution and descriptive sensory evaluations were performed (Table 1).
Descriptive sensory evaluations were carried out using different amounts of sebacic acid in different applications. The results of this analysis, as compared to the same applications in the absence of sebacic acid, are presented in Table 2.
Sweetened milk (2% fat milk with 2% sucrose) was prepared and used as a base solution (“base”). Sebacic acid and traumatic acid were added to the base solution and descriptive sensory evaluations were performed (Table 3)
The results of this analysis indicated that sebacic acid (2 ppm) and traumatic acid (2 ppm) each increased sweetness and mouthfeel of sweetened milk. When used together, sebacic acid (2 ppm) and traumatic acid (2 ppm) provided the most increase in sweetness and mouthfeel.
In addition, the sweetness and mouthfeel enhancement as well as off-flavor masking of sebacic acid was compared with a series of analogs including adipic acid, pimelic acid, suberic acid, undecanedioic acid, dodecanedioic acid, 1,11-undecanedicarboxylic acid, tetradecanedioic acid and hexadecanedioic acid at 2 ppm. Among all the compounds tested, sebacic acid exhibited the strongest and the longest-lasting effect, which was significantly superior to all other compounds.
This application claims benefit of priority to U.S. Provisional Patent Application Ser. No. 62/776,150, filed Dec. 6, 2018, the content of which is incorporated herein by reference in its entirety.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/US2019/064589 | 12/5/2019 | WO | 00 |
| Number | Date | Country | |
|---|---|---|---|
| 62776150 | Dec 2018 | US |
